Clinical trials: Embolism
Thromboembolism, Pregnancy
Pregnancy and Risk of Venous Thromboembolism
The management of venous thromboembolism (VTE) risk in pregnancy still remains a challenge. An individual assessment of the VTE risk is crucial for optimal thromboprophylaxis, but there is no validated tool to help clinicians…
- Trial name
- PRESCOT (NCT03659708)
- Testing
- Lyon-VTE score, recommendations currently available
- Where
- France
- Volunteers
- 600 people
- Sponsor
- Hospices Civils de Lyon
Pain, Hypoglycemia
Outcomes Study of MTM in a Medicare ACO
This is a non-randomized, prospective, quasi-experimental study designed to assess the impact of pharmacist-provided medication management on total cost of care and clinical outcomes (ie, hospitalizations, emergency department…
- Trial name
- NCT02875925
- Testing
- MTM
- Where
- United States
- Volunteers
- 77 people, healthy volunteers welcome
- Sponsor
- HealthEast Care System
Large-Artery Atherosclerosis (Embolus/Thrombosis)
18F-S2P PET Imaging in the Evaluation of Large Artery Atherosclerosis
The aim of this study is to evaluate the lesion detection performance and safety of 18F-S2P positron emission tomography (PET) in patients with large-artery atherosclerosis.
- Trial name
- NCT07815860
- Testing
- 18F-S2P
- Where
- China
- Volunteers
- 200 people
- Sponsor
- First Affiliated Hospital of Zhejiang University
Deep Vein Thrombosis Leg
The Venous Thrombus Extraction (VETEX) Clinical Study: A Preliminary Investigation
This is an open label, prospective, non-randomised, multi-centre first-in-human evaluation of the Vetex Thrombectomy Device for treatment of acute iliofemoral deep vein thrombosis (DVT)
- Trial name
- VETEX (NCT03489135)
- Testing
- ReVene Thrombectomy Catheter
- Where
- 5 sites in Bulgaria, Germany and 2 more
- Volunteers
- 19 people
- Sponsor
- Vetex Medical Ltd.
Pulmonary Embolism
Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy
PE-TRACT is an open-label, assessor-blinded, randomized trial, aiming to compare catheter-directed therapy (CDT) and anticoagulation (CDT group) with anticoagulation alone (No-CDT) in 500 patients with submassive PE, proximal…
- Trial name
- PE-TRACT (NCT05591118)
- Testing
- Anticoagulant Therapy, Catheter-Directed Therapy
- Where
- 40 sites in United States
- Volunteers
- 500 people
- Sponsor
- NYU Langone Health
Amniotic Fluid Embolism
Analysis of Factors Associated With The Occurrence of Amniotic Fluid Entry in Patients Undergoing Caesarean Section
To compare serum STN （Neuraminic acid-N-acetylgalactose）antigen concentrations in patients undergoing cesarean section and to study the factors associated with amniotic fluid entry.Compare the serum complement C4 concentration in…
- Trial name
- AOFAWTOOAFEIPU (NCT06991985)
- Testing
- Enzyme-linked immunosorbent assay
- Where
- China
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- Second Hospital of Shanxi Medical University
Deep Vein Thrombosis
Destiny: D-dimer. Investigating D-dimer Levels Using Point-of-Care (POC) Testing at Primary Care.
DESTINY D-Dimer is an observational feasibility study, and a collaboration between the University of South Wales and Cwm Taf Morgannwg University Health Board (CTMUHB). The study is based at St.
- Trial name
- Destiny (NCT05109260)
- Testing
- Point-of-Care Immunoassay device
- Where
- 2 sites in United Kingdom
- Volunteers
- 244 people
- Sponsor
- University of South Wales
Ankle Motion, Gynecologic Neoplasm
Functional Training for the Prevention of Deep Venous Thrombosis
This study aims to analyze the post-operative functional training on the prevention of deep venous thrombosis (DVT) in the patients who have accepted major surgeries for the gynecological malignancies.
- Conditions
- Ankle Motion, Gynecologic Neoplasm, Deep Venous Thrombosis, Abdominal Breathing
- Trial name
- NCT03740633
- Testing
- passive ankle pump motions on the day of surgery, active ankle pump motions and abdominal breathing training on the 1-3 day after the surgery, Regular care
- Where
- China
- Volunteers
- 398 people
- Sponsor
- Lei Li
Coronary Artery Disease, Peripheral Arterial Disease
NEtwork to Control ATherothrombosis (NEAT Registry)
NEAT is an observational cohort (Prospective registry of real world data) of patients with coronary and peripheral artery disease in an outopatient setting.
- Conditions
- Coronary Artery Disease, Peripheral Arterial Disease, Atherothrombosis
- Trial name
- NEAT (NCT04677725)
- Where
- Brazil
- Volunteers
- 2,000 people
- Sponsor
- Hospital do Coracao
Deep-Vein Thrombosis, Pulmonary Embolism
VITRO-Trial. B Vitamins and the Secondary Prevention of Venous Thrombosis
The VITRO (Vitamins and Thrombosis) study investigated the effect of homocysteine lowering by daily supplementation of B-vitamins on the risk reduction of deep-vein thrombosis and pulmonary embolism.
- Trial name
- NCT00314990
- Testing
- 5 mg folic acid, 50 mg pyridoxine and 0.4 mg cyanocobalamin
- Where
- Netherlands
- Volunteers
- 620 people
- Sponsor
- Radboud University Medical Center
Raynaud Phenomenon
Dermoscopy in Primary Raynaud's Phenomenon
Raynaud's phenomenon (RP) is very frequent in general population (up to 10%). Nailfold capillaroscopy (NFC) is recommended for patients presenting RP, to eliminate systemic disease such as systemic sclerosis.
- Trial name
- VASCUL-R (NCT04644523)
- Testing
- Dermoscopy
- Where
- France
- Volunteers
- 100 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Coronary Stenosis, Coronary Thrombosis
Monitoring Response to Antiplatelet Therapy
Antiplatelet therapy plays a key role in the prevention of complications related to coronary angioplasty and stenting (PCI) including procedure related myocardial damage.
- Conditions
- Coronary Stenosis, Coronary Thrombosis, Angioplasty, Balloon
- Trial name
- NCT00327041
- Where
- United Kingdom
- Volunteers
- 40 people
- Sponsor
- NHS Greater Glasgow and Clyde
Atrial Fibrillation
Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Asia
This is an international observational study in patients with non-valvular atrial fibrillation who are prescribed rivaroxaban under routine treatment conditions to prevent stroke or non-central nervous system systemic embolism.
- Trial name
- XANAP (NCT01750788)
- Testing
- Rivaroxaban (Xarelto, BAY59-7939)
- Where
- 11 sites in Hong Kong, India and 9 more
- Volunteers
- 2,297 people
- Sponsor
- Bayer
Pediatric Venous Thromboembolism
Rivaroxaban in Pediatric Patients With DVT
Prospective interventional randomized controlled trial to assess safety and efficacy of rivaroxaban in pediatric patients with acute deep venous thrombosis.
- Trial name
- NCT07618988
- Testing
- Rivaroxaban, Enoxaparin, Heparin
- Where
- Egypt
- Volunteers
- 60 people
- Sponsor
- Ain Shams University
Retinal Vein Occlusion
Continuing Assessment of Patients Treated With ranibizUmab for REtinal Vein Occlusion (CAPTURE)
This research is being done to assess the long term prognosis of patients treated with ranibizumab for edema due to retinal vein occlusion.
- Trial name
- CAPTURE (NCT01875770)
- Where
- United States
- Volunteers
- 47 people
- Sponsor
- Johns Hopkins University
Venous Thromboembolism, Deep Vein Thrombosis
SToP: Venous Thromboembolism Screening in the Trauma Population
This is a prospective, randomized vanguard trial of trauma patients admitted to the trauma surgery service at Intermountain Medical Center who are deemed to be at high risk for venous thromboembolism.
- Conditions
- Venous Thromboembolism, Deep Vein Thrombosis, Trauma, Multiple
- Trial name
- SToP (NCT02978950)
- Testing
- Duplex ultrasound surveillance, No ultrasound surveillance
- Where
- United States
- Volunteers
- 2,000 people
- Sponsor
- Intermountain Health Care, Inc.
Systemic Sclerosis, Fatigue
Apollo Device for Fatigue in Systemic Sclerosis
The purpose of this study is to learn about the effect of Apollo (a vibrating wearable about the side of an Apple Watch) on fatigue, Raynaud symptoms, depression, quality of life, and disease symptoms in patients with systemic…
- Conditions
- Systemic Sclerosis, Fatigue, Raynaud Phenomenon
- Trial name
- NCT04854850
- Testing
- Apollo
- Where
- United States
- Volunteers
- 25 people
- Sponsor
- Robyn T. Domsic, MD, MPH
Prosthetic Valve Thrombosis
Comparison of Different TRansesophageal Echocardiography Guided thrOmbolytic Regimens for prosthetIc vAlve Thrombosis
Despite high mortality and morbidity, the best treatment strategies for prosthetic valve thrombosis (PVT) have been controversial.
- Trial name
- TROIA (NCT01451320)
- Testing
- Streptokinase, Tissue plasminogen activator
- Where
- Turkey (Türkiye)
- Volunteers
- 182 people
- Sponsor
- Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital
Venous Thromboembolism (VTE), Cancer
Vortosiran for VTE Prevention
Blood clots remain a serious cause of illness and death. Long-term treatment and prevention of these clots with blood thinners is often limited by bleeding risk, drug interactions, and daily dosing, leading many patients to stop…
- Conditions
- Venous Thromboembolism (VTE), Cancer, Pulmonary Embolism (Diagnosis)
- Trial name
- NCT07850453
- Testing
- Vortosiran
- Where
- 30 sites in Bulgaria, France and 2 more
- Volunteers
- 150 people
- Sponsor
- Ribocure Pharmaceuticals AB
Central Retinal Vein Occlusion
Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein Occlusion
Central retinal vein occlusion (CRVO) is a common cause of vision loss, typically affecting individuals during the fifth through seventh decade of life.
- Trial name
- NCT01581411
- Testing
- Tissue Plasminogen Activator
- Where
- United States
- Volunteers
- 1 people
- Sponsor
- Weill Medical College of Cornell University